Get startedLog in
    Picture of CNS Pharmaceuticals logo

    CNSP — CNS Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: CNS Pharmaceuticals Berubicin Trial Is On Schedule To Commence In March 2021

    Picture of CNS Pharmaceuticals logoCNS Pharmaceuticals
    25/02/2021 14:24
    Feb 25 (Reuters) - CNS Pharmaceuticals Inc  CNSP.O :
    * CNS PHARMACEUTICALS BERUBICIN TRIAL IS ON SCHEDULE TO
COMMENCE
IN MARCH 2021

Source text for Eikon:  ID:nPn7DByrTa 
Further company coverage:  CNSP.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on CNS Pharmaceuticals

    See all news